Xuriden: payments to doctors
Payments that named Xuriden as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $351K
- Providers
- 2
- Transactions
- 22
- Average per transaction
- $15,952
The per-transaction average — $15,952 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2 providers the average total is $175,471, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| BTG International, Inc. | $314,105 | 89.5% |
| BTG International Inc. | $36,838 | 10.5% |